> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# White House Nixes Overton FDA Nomination; Sen. Marshall is Possible Replacement
- URL: https://www.fdaweb.com/sen-marshall-emerges-as-possible-fda-nominee-as-overton-vote-nears/
- Published: 2026-11-17T23:58:46.000Z
- Updated: 2026-11-18T00:26:09.000Z
- Author: David McFarland
- Tags: FDA Policy/General

The White House is withdrawing **Heidi Overton**'s nomination as FDA commissioner due to a lack of congressional support, Axios reported 11/17, just hours before her closely watched Senate committee vote.

The decision follows mounting opposition from Democrats and reservations among Republicans, including Senate Health, Education, Labor and Pensions Committee chairman **Bill Cassidy** (R-LA), who had questioned Overton's involvement in administration vaccine policies.

As [previously reported by ***FDA Webview***](https://www.fdaweb.com/overtons-confirmation-on-shaky-ground-as-cassidy-still-has-questions/), Cassidy remained undecided about supporting Overton ahead of the 11/18 vote.

[Semafor has reported](https://www.semafor.com/article/11/17/2026/republicans-consider-marshall-a-viable-fda-pick-as-overton-wobbles?ref=fdaweb.com) that Republicans were discussing Sen. **Roger Marshall** (R-KS), a physician who lost his reelection bid earlier this month, as a possible replacement. No new nominee has been announced.

A senior administration official told Axios that the White House wants a new direction at FDA consistent with HHS secretary **Robert F. Kennedy Jr**.'s Make America Healthy Again agenda.

The withdrawal leaves FDA under acting commissioner **Kyle Diamantas** as the administration searches for a permanent agency chief.